Prognostic value for overall survival of the EORTC QLQ-C30 Summary Score: An analysis of 5 closed EORTC trials
European Journal of Cancer · 2026-06 · 241 · 116774
DOI: 10.1016/j.ejca.2026.116774 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-06. Verfasst von Josien C C Scheepens und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: j.c.c.scheepens@lumc.nl. Hauptthemen laut MEDLINE: Quality of Life, Neoplasms. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Organisation for Research and Treatment of Cancer.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: j.c.c.scheepens@lumc.nl.
- European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
- Division of Psychosocial Research & Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
- Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
- Department of Radiation Oncology (MAASTRO), Maastricht University Medical Center and GROW School for Oncology, Maastricht, Netherlands; Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty…
- Breast Unit, Helios University Hospital Wuppertal, Wuppertal, Germany; University Witten/Herdecke, Germany.
Förderung
- European Organisation for Research and Treatment of Cancer
Zitieren
APA
Scheepens, J. C. C., Lim, L., Musoro, J. Z., Aaronson, N. K., Dirven, L., Baumert, B. G., Bjelic-Radisic, V., Bolla, M., Coens, C., Galinsky, J., van der Graaf, W. T. A., Husson, O., Kyriakou, C., O'Brien, M., Rammant, E., Turhal, N. S., Petersen, M. A., Grønvold, M., Taphoorn, M. J. B., …, & EORTC Quality of Life Group (2026). Prognostic value for overall survival of the EORTC QLQ-C30 Summary Score: An analysis of 5 closed EORTC trials. European Journal of Cancer, 241, 116774. https://doi.org/10.1016/j.ejca.2026.116774
Vancouver
Scheepens JCC, Lim L, Musoro JZ, Aaronson NK, Dirven L, Baumert BG, et al. Prognostic value for overall survival of the EORTC QLQ-C30 Summary Score: An analysis of 5 closed EORTC trials. European Journal of Cancer. 2026;241:116774. doi:10.1016/j.ejca.2026.116774
BibTeX
@article{Scheepens2026,
author = {Scheepens, Josien C C and Lim, Luigi and Musoro, Jammbe Z and Aaronson, Neil K and Dirven, Linda and Baumert, Brigitta G and Bjelic-Radisic, Vesna and Bolla, Michel and Coens, Corneel and Galinsky, Jayne and van der Graaf, Winette T A and Husson, Olga and Kyriakou, Charalampia and O'Brien, Mary and Rammant, Elke and Turhal, Nazim Serdar and Petersen, Morten Aa and Grønvold, Mogens and Taphoorn, Martin J B and Koekkoek, Johan A F and Giesinger, Johannes M and EORTC Quality of Life Group, EORTC Quality of Life Group},
title = {Prognostic value for overall survival of the EORTC QLQ-C30 Summary Score: An analysis of 5 closed EORTC trials},
journal = {European Journal of Cancer},
year = {2026},
volume = {241},
pages = {116774},
doi = {10.1016/j.ejca.2026.116774}
}
EUVIMED